DELANEY KAISER: Open Payments
NPI 1699256214 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 56 payments from 17 companies in 2025. Trend: 2023 $287 · 2024 $493 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $166 |
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Lundbeck LLC | 3 | $59 |
| PFIZER INC. | 3 | $53 |
| Amgen Inc. | 3 | $47 |
| Abbott Laboratories | 2 | $47 |
| Exact Sciences Corporation | 2 | $45 |
Products named: BREZTRI, Auvelity, QULIPTA, CAPLYTA, REXULTI, NURTEC ODT, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
